Ignite Creation Date:
2025-12-24 @ 3:03 PM
Ignite Modification Date:
2025-12-25 @ 9:55 PM
Study NCT ID:
NCT01091259
Status:
COMPLETED
Last Update Posted:
2015-11-24
First Post:
2010-03-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Irinotecan and Bevacizumab for Recurrent Ovarian Cancer
Sponsor:
NYU Langone Health
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-03
Start Date Type:
None
Primary Completion Date:
2014-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-05
Completion Date Type:
ACTUAL
First Submit Date:
2010-03-19
First Submit QC Date:
None
Study First Post Date:
2010-03-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-08-21
Results First Submit QC Date:
None
Results First Post Date:
2015-10-19
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-10-26
Last Update Post Date:
2015-11-24
Last Update Post Date Type:
ESTIMATED